Title: The future of antivirals: broad-spectrum inhibitors
Authors: Debing, Yannick ×
Neyts, Johan
Delang, Leen #
Issue Date: Dec-2015
Publisher: Rapid Science Publishers
Series Title: Current Opinion in Infectious Diseases vol:28 issue:6 pages:596-602
Abstract: Potent antivirals are successfully used for the treatment of infections with herpesviruses, hepatitis B and C viruses, HIV, and with some success for influenza viruses. However, no selective inhibitors are available for a multitude of medically important viruses, most of which are (re-)emerging RNA viruses. As it is impossible to develop drugs against each of these viruses, broad-spectrum antiviral agents (BSAA) are a prime strategy to cope with this challenge.
ISSN: 0951-7375
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Virology and Chemotherapy (Rega Institute)
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Curr Opin Infect Dis Debing.pdf Published 469KbAdobe PDFView/Open
2015216.pdf Published 143KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science